These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 8610215

  • 1. Comparison of intramuscular gold and sulphasalazine in the treatment of early rheumatoid arthritis. A one year prospective study.
    Peltomaa R, Paimela L, Helve T, Leirisalo-Repo M.
    Scand J Rheumatol; 1995; 24(6):330-5. PubMed ID: 8610215
    [Abstract] [Full Text] [Related]

  • 2. Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate.
    Pullar T, Hunter JA, Capell HA.
    Br Med J (Clin Res Ed); 1983 Oct 15; 287(6399):1102-4. PubMed ID: 6138117
    [Abstract] [Full Text] [Related]

  • 3. Treating rheumatoid arthritis early with disease modifying drugs reduces joint damage: a randomised double blind trial of sulphasalazine vs diclofenac sodium.
    Choy EH, Scott DL, Kingsley GH, Williams P, Wojtulewski J, Papasavvas G, Henderson E, Macfarlane D, Erhardt C, Young A, Plant MJ, Panayi GS.
    Clin Exp Rheumatol; 2002 Oct 15; 20(3):351-8. PubMed ID: 12102471
    [Abstract] [Full Text] [Related]

  • 4. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis.
    Boers M, Verhoeven AC, Markusse HM, van de Laar MA, Westhovens R, van Denderen JC, van Zeben D, Dijkmans BA, Peeters AJ, Jacobs P, van den Brink HR, Schouten HJ, van der Heijde DM, Boonen A, van der Linden S.
    Lancet; 1997 Aug 02; 350(9074):309-18. PubMed ID: 9251634
    [Abstract] [Full Text] [Related]

  • 5. Adverse reactions to parenteral gold salts.
    Tilelli JA, Heinrichs MM.
    Lancet; 1997 Mar 22; 349(9055):853. PubMed ID: 9121270
    [No Abstract] [Full Text] [Related]

  • 6. Skin reaction associated with chrysotherapy: an unusual case.
    Carlucci F, Chimenti MS, Priori R, Tentolini U, Marasco A, Valesini G.
    Clin Exp Rheumatol; 2004 Mar 22; 22(1):136. PubMed ID: 15005022
    [No Abstract] [Full Text] [Related]

  • 7. Termination of disease-modifying antirheumatic drugs in rheumatoid arthritis and in psoriatic arthritis. A comparative study of 270 cases.
    Ujfalussy I, Koó E, Seszták M, Gergely P.
    Z Rheumatol; 2003 Apr 22; 62(2):155-60. PubMed ID: 12721703
    [Abstract] [Full Text] [Related]

  • 8. The ability of disease modifying antirheumatic drugs to induce and maintain improvement in patients with rheumatoid arthritis. epidemiology of DMARDs treatment in Japan.
    Nagashima M, Shu G, Yamamoto K, Yamahatsu S, Yoshino S.
    Clin Exp Rheumatol; 2005 Apr 22; 23(1):27-35. PubMed ID: 15789884
    [Abstract] [Full Text] [Related]

  • 9. [Analysis of efficacy and safety of multiple intravenous infusion of anti-tumor necrosis factor-alpha monoclonal antibody (Remicade) combined with methotrexate compared with sodium aurothiomalate and intramuscular depot methylprednisolone in rheumatoid arthritis].
    Wiland P, Głowska A, Chlebicki A, Szechiński J.
    Pol Arch Med Wewn; 2002 Nov 22; 108(5):1055-63. PubMed ID: 12685246
    [Abstract] [Full Text] [Related]

  • 10. Low dose desensitisation does not reduce the toxicity of sulphasalazine in rheumatoid arthritis.
    McInnes IB, Porter D, Murphy EA, Thomson EA, Madhok R, Hunter JA, Pullar T, Capell HA.
    Ann Rheum Dis; 1996 May 22; 55(5):328-30. PubMed ID: 8660109
    [Abstract] [Full Text] [Related]

  • 11. Outcome of attempts to treat rheumatoid arthritis with gold, penicillamine, sulphasalazine, or dapsone.
    Grindulis KA, McConkey B.
    Ann Rheum Dis; 1984 Jun 22; 43(3):398-401. PubMed ID: 6146295
    [Abstract] [Full Text] [Related]

  • 12. [The effect of parenteral gold preparations on heart function in rheumatoid arthritis patients (based on echocardiographic data)].
    Nemchinov EN, Chichasova NV, Kanevskaia MZ, Slobodina GA.
    Revmatologiia (Mosk); 1989 Jun 22; (4):23-8. PubMed ID: 2576902
    [Abstract] [Full Text] [Related]

  • 13. A 10 year follow up of parenteral gold therapy in patients with rheumatoid arthritis.
    Bendix G, Bjelle A.
    Ann Rheum Dis; 1996 Mar 22; 55(3):169-76. PubMed ID: 8712879
    [Abstract] [Full Text] [Related]

  • 14. Sulphasalazine in rheumatoid arthritis: combination therapy with D-penicillamine or sodium aurothiomalate.
    Farr M, Kitas G, Bacon PA.
    Clin Rheumatol; 1988 Jun 22; 7(2):242-8. PubMed ID: 2901303
    [Abstract] [Full Text] [Related]

  • 15. Combination of sulphasalazine and methotrexate in the treatment of rheumatoid arthritis.
    Dougados M.
    Z Rheumatol; 1998 Feb 22; 57(1):31-3. PubMed ID: 9566104
    [No Abstract] [Full Text] [Related]

  • 16. [Experiences in long-term therapy of rheumatoid arthritis with sulfasalazine tablets].
    Amos RS.
    Z Rheumatol; 1987 Feb 22; 46(2):76-8. PubMed ID: 2885988
    [Abstract] [Full Text] [Related]

  • 17. Progression of joint damage in early active severe rheumatoid arthritis during 18 months of treatment: comparison of low-dose cyclosporin and parenteral gold.
    Zeidler HK, Kvien TK, Hannonen P, Wollheim FA, Førre O, Geidel H, Hafström I, Kaltwasser JP, Leirisalo-Repo M, Manger B, Laasonen L, Markert ER, Prestele H, Kurki P.
    Br J Rheumatol; 1998 Aug 22; 37(8):874-82. PubMed ID: 9734679
    [Abstract] [Full Text] [Related]

  • 18. HLA types in patients with rheumatoid arthritis developing leucopenia after both gold and sulphasalazine treatment.
    Bliddal H, Eiberg B, Helin P, Svejgaard A.
    Ann Rheum Dis; 1989 Jul 22; 48(7):539-41. PubMed ID: 2570550
    [Abstract] [Full Text] [Related]

  • 19. Evidence for immunostimulatory effects of intramuscular gold in patients with rheumatoid arthritis: correlation with skin reactions.
    Ernestam S, Lampa J, Rogberg S, Rönnelid J, Klareskog L, Hafström I.
    J Rheumatol; 2003 Aug 22; 30(8):1748-55. PubMed ID: 12913930
    [Abstract] [Full Text] [Related]

  • 20. Radiographic outcome after three years of patients with early erosive rheumatoid arthritis treated with intramuscular methotrexate or parenteral gold. Extension of a one-year double-blind study in 174 patients.
    Rau R, Herborn G, Menninger H, Sangha O.
    Rheumatology (Oxford); 2002 Feb 22; 41(2):196-204. PubMed ID: 11886970
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.